Sign inJoin waitlistJoin the waitlist

Karie Danielle Keera Runcie

Assistant Professor of Medicine · Columbia University Medical Center

Credentials: · · · ·

History

Columbia University Medical Center
Present

Research

Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeutics
Review · Molecular Medicine · 2018 · First of 4 authors · 133 citations
Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer
Cancer Cell · 2023 · 75 citations
Safety and clinical activity of BMS-986365 (CC-94676), a dual androgen receptor ligand-directed degrader and antagonist, in heavily pretreated patients with metastatic…
Annals of Oncology · 2025 · 67 citations

Mark Stein
9 papers
Alexander Wei
5 papers
Eric Singer
5 papers
Guarionex DeCastro
5 papers
James McKiernan
5 papers
Michael Liu
5 papers
MD
Matthew Dallos
4 papers
Aleksandar Obradovic
3 papers · 3 as a resident
CD
Charles Drake
3 papers
Renu Virk
3 papers
Andrew Lenis
2 papers
Benjamin Joffe
2 papers · 2 as a resident

Clinical trials

Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC
Principal investigator · Recruiting · Phase 2
Karie Runcie
2026–2028
Non-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate Cancer
Principal investigator · Completed · Early phase 1
Columbia University
2020–2025
A Study of Combination Spartalizumab and Canakinumab in Patients With Localized Clear Cell Renal Cell Carcinoma
Principal investigator · Completed · Early phase 1
Columbia University
2019–2026
Study of Talimogene Laherparepvec (T-VEC) in Pancreatic Cancer
Principal investigator · Completed · Phase 1
Karie D. Runcie, MD
2017–2022